Ignite Creation Date:
2024-05-06 @ 3:18 AM
Last Modification Date:
2024-10-26 @ 11:31 AM
Study NCT ID:
NCT02258321
Status:
COMPLETED
Last Update Posted:
2015-01-22
First Post:
2014-10-02
Brief Title:
Phase 1 Study of Relative Bioavailability of PPI-668 New Tablet Versus Capsule Formulations
Sponsor:
Presidio Pharmaceuticals Inc
Organization:
Presidio Pharmaceuticals Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Pharmacokinetic Assessments in Healthy Volunteers |
Keywords: